Skip to main content
. Author manuscript; available in PMC: 2018 Oct 25.
Published in final edited form as: J Med Chem. 2010 May 13;53(9):3489–3501. doi: 10.1021/jm901691y

Table 4.

FAC−MS Data in Comparison with [35S]GTPyS Binding Results Obtained on GPR17-IAM-II and Mutated GPR17-IAMa

GPR17-IAM-II
mutated-GPR17-IAM
compd tb (min) EC 50 IC50 c(nM) tb (min) EC50 IC50c (nM)
UDP 2.69 1.14 ± 0.2/µM 2.15 3.0 ± 0.3 µM
13 2.79 945 ± 48 nM 2.51 1.87 ± 0.20 µM
12 3.55 582 ± 57
MRS2179 3.62 508 ± 29 3.47 227 ± 22
5 3.69 112 ± 7
7 4.5 11 ± 1 nM
8 4.77 1.7 ± 0.1 nM
6 5.67 1.4 ± 0.1 nM
cangrelor 10.6 0.7 ± 0.02 13.16 0.15 ±0.01
4 13.07 36 ± 3 pM 16.07 25.4 ± 1.0 pM
a

Columns: GPR17-IAM-II (19.5 million cells), mutated GPR17-IAM (19.5 million cells)

b

t is the breakthrough time of the ligand with the immobilized GPR17.

c

Versus UDP-glucose 10 µM.